A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

CVS Caremark is facing a lawsuit after being accused of pointing patients to use a weight loss drug called Wegovy and for ...

A new class-action lawsuit alleges CVS Caremark unlawfully changed its coverage for popular GLP-1 drug Zepbound. | A new ...

A class action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lily’s ...

A class-action lawsuit filed against CVS Caremark argues that the PBM dropping coverage of Zepbound for Wegovy is illegal.

Two New York residents have filed a lawsuit against CVS after the company’s pharmacy benefit manager, Caremark, denied coverage for Zepbound in favor of Wegovy. The plaintiffs — Dennis Larkin of ...

Novo Nordisk A/S is poised for long-term growth despite job cuts and margin resets. Click here to find out why NVO stock is a ...

CVS Caremark is facing multiple federal lawsuits by patients challenging its decision to remove weight-loss drug Zepbound ...

“Obesity is a complex disease,” says Shauna Levy, medical director of the Tulane School of Medicine’s Bariatric and Weight Loss Center. “The fact is that not everyone responds to the same treatments, ...

After losing 50 pounds on the injectable weight loss medication Zepbound, Kyra Wensley received a surprising letter from her ...

As evidence grows supporting the potential health benefits of obesity drugs like Novo Nordisk’s Wegovy and Eli Lilly & Co.’s ...